Hydrofarm Group (HYFM) Q4 2024 earnings summary

Executive summary

• 2024 saw notable operational improvements, but a challenging second half, especially Q4, due to industry oversupply and retail closures led to lower sales across the supply chain.

• Net sales declined 20.9% year-over-year in Q4 2024 to $37.3M, and full-year sales fell 16% to $190.3M.

• Strategic focus on higher-margin proprietary brands increased their sales mix from 35% in 2020 to 56% in 2024, supporting profitability in most quarters despite industry headwinds.

• Adjusted EBITDA was negative at $(7.3)M for Q4 and $(5.2)M for the year, reflecting industry headwinds and lower gross margins.

• Cost management initiatives led to a 16.9% reduction in adjusted SG&A for the year, with $9M in annual savings.

Financial highlights

• Q4 net sales were $37.3 million, down 20.9% year-over-year, driven by a 16.8% decrease in volume and 3.9% decline in pricing.

• Q4 gross profit was $1.8 million (4.9% margin), down from $8.4 million (17.9%) last year; adjusted gross profit was $3.6 million (9.6% margin), down from $11.5 million (24.3%).

• Q4 adjusted EBITDA loss was $7.3 million, attributed to lower sales and gross profit, partially offset by SG&A savings.

• Cash balance at year-end was $26.1 million, with $119.3 million in term debt and $39 million in total liquidity.

• Q4 free cash flow was $2.4 million; full-year free cash flow was negative $(3.2) million.

Outlook and guidance

• 2025 net sales expected to decline 10–20% year-over-year, but adjusted gross profit margin is projected to increase due to improved proprietary brand mix and cost savings.

• Adjusted EBITDA expected to remain negative but improve versus 2024, with further SG&A reductions and operational efficiencies.

• No significant non-restructuring inventory or receivable charges anticipated for 2025; free cash flow expected to improve.

• Capital expenditures projected below $2M for 2025.